Representation of Surgical Device and Implant Manufacturer: United States v. ArthroCare Corp. (W.D. Tex.)

We represented a developer and manufacturer of surgical devices and implants, in a five-year DOJ securities fraud investigation into whether senior executives defrauded investors. ArthroCare agreed to pay $30 million and entered into a deferred prosecution agreement to end the investigation. The $30 million represented an almost 50% reduction of the amount of fine that could have been levied against the company under the U.S. Sentencing Guidelines due to its extensive remedial and cooperation efforts. Furthermore, DOJ did not require a monitor.

We represented a developer and manufacturer of surgical devices and implants, in a five-year DOJ securities fraud investigation into whether senior executives defrauded investors. ArthroCare agreed to pay $30 million and entered into a deferred prosecution agreement to end the investigation. The $30 million represented an almost 50% reduction of the amount of fine that could have been levied against the company under the U.S. Sentencing Guidelines due to its extensive remedial and cooperation efforts. Furthermore, DOJ did not require a monitor.